NEW YORK, Sept. 30 /PRNewswire/ — Reportlinker.com announces
that a new market research report is available in its
catalogue:
http://www.reportlinker.com/p0305169/Global-Protein-Drugs-Industry.html
This report analyzes the Global market for Protein Drugs in US$
Million by the following Drug Classes – Antibodies, Blood Products,
Cytokines, Peptide Hormones, Vaccines, and Others (Including
Peptide Antibiotics and Enzymes). Annual estimates and forecasts
are provided for the period 2006 through 2015. The report profiles
56 companies including many key and niche players such as Abbott
Laboratories, Inc., Alexion Pharmaceuticals, Inc., Amgen, Inc.,
Biogen Idec, Bristol-Myers Squibb Company, Medarex, Inc., Crucell
N.V., Dendreon Corporation, Eli Lilly and Company, Emergent
BioSolutions, Inc., Genentech, Inc., Johnson & Johnson,
Centocor Ortho Biotech, Inc., MedImmune, Inc., Merck Serono S.A.,
Schering-Plough Corporation, UCB Group, Unigene Laboratories, Inc.,
and Vaccinogen, Inc. Market data and analytics are derived from
primary and secondary research. Company profiles are mostly
extracted from URL research and reported select online sources.
PROTEIN DRUGS MCP-6377
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
A Prelude II-1
Protein Drugs Are the Best Sellers II-1
Key Statistics: II-2
‘/>”/>
